Our results show that the absence of Mlkl or Ripk3 reduced liver inflammaging and age-associated MASLD pathology; however, the absence of these proteins had differential effects on lifespan and metabolic health. This evidence concerns the gene MLKL and metabolic dysfunction-associated steatotic liver disease.